The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adiposity and response to androgen signaling inhibition (ASI) in men with metastatic castration-resistant prostate cancer (mCRPC).
 
Andrew Warren Hahn
No Relationships to Disclose
 
Rebecca Tidwell
Research Funding - Galera Therapeutics (Inst)
 
Devaki Shilpa Surasi
No Relationships to Disclose
 
Patrick Glen Pilie
Patents, Royalties, Other Intellectual Property - Patent Pending- biomarker
 
Daniel Frigo
No Relationships to Disclose
 
Sumit Kumar Subudhi
Stock and Other Ownership Interests - Apricity Health
Honoraria - Amgen; Apricity Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Dava Oncology; Dendreon; Exelixis; Janssen; Parker Institute for Cancer Immunotherapy; Polaris; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Amgen; Apricity Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Dava Oncology; Dendreon; Janssen; Polaris; Valeant/Dendreon
Research Funding - AstraZeneca; Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Compugen; Dava Oncology; Dendreon; Janssen; Parker Institute for Cancer Immunotherapy; Society for Immunotherapy of Cancer
 
Eleni Efstathiou
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bayer; Janssen; Merck; ORIC Pharmaceuticals; Pfizer; Sanofi
Research Funding - Astellas Oncology (Inst); AstraZeneca (Inst); Bayer (Inst); Janssen (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Sanofi (Inst)
 
Amado J. Zurita
Honoraria - Exelixis; Janssen Oncology; Pfizer
Consulting or Advisory Role - Exelixis
Research Funding - Infinity Pharmaceuticals; Pfizer
 
Shi-Ming Tu
Consulting or Advisory Role - Janssen Biotech
 
Brian Francis Chapin
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen
 
David R. Fogelman
Employment - Merck
Stock and Other Ownership Interests - GTx
Consulting or Advisory Role - Incyte
 
Michael W Starbuck
No Relationships to Disclose
 
Paul G. Corn
Research Funding - Janssen Oncology (Inst)
 
Ana Aparicio
Honoraria - Biosense Webster (I); Boston Scientific (I); Genzyme
Consulting or Advisory Role - American Cancer Society; American Cancer Society; Biosense Webster (I); Boston Scientific (I); Janssen Research & Development
Speakers' Bureau - Biosense Webster (I); Boston Scientific (I)
Research Funding - BioSense Webster (I); Boston Scientific (I); Bristol-Myers Squibb (Inst); Hansen Medical (I); Janssen (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Two (I)
Travel, Accommodations, Expenses - Biosense WEbster (I)
 
Jennifer Leigh McQuade
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Merck
 
Christopher Logothetis
Honoraria - Amgen; Bayer; Exelixis; Merck Sharp & Dohme
Consulting or Advisory Role - Amgen; Bayer; Exelixis; Merck Sharp & Dohme
Research Funding - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi